
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $3.7B | $4.1B | $3.3B | $3.4B | $3.5B | |
Revenue Growth (YoY) | 16.76% | 10.32% | -19.12% | 3.31% | 2.72% | |
Cost of Revenues | $3B | $3.3B | $2.8B | $3B | $3.1B | |
Gross Profit | $742.3M | $824.7M | $513.6M | $476.3M | $435.1M | |
Gross Profit Margin | 19.97% | 20.11% | 15.49% | 13.9% | 12.36% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $462.5M | $473.3M | $1.9B | $388.7M | $401.6M | |
Operating Income | $279.8M | $351.4M | -$1.4B | $87.7M | $33.6M | |
Net Interest Expenses | $19.4M | $26M | $21.1M | $2.2M | $7.6M | |
EBT. Incl. Unusual Items | $322.1M | $357.3M | -$1.4B | $84.4M | $27.1M | |
Earnings of Discontinued Ops. | $4.6M | $34.3M | -$11.6M | $1.1M | -$1.1M | |
Income Tax Expense | $78.8M | $87.6M | -$348M | $26M | $6.5M | |
Net Income to Company | $322.1M | $357.3M | $48.5M | $84.4M | $27.1M | |
Minority Interest in Earnings | -- | -$1.2M | -- | -- | -$1.1M | |
Net Income to Common Excl Extra Items | $247.8M | $304.1M | -$1B | $59.5M | $18.4M | |
Basic EPS (Cont. Ops) | $0.50 | $0.60 | -$2.13 | $0.12 | $0.04 | |
Diluted EPS (Cont. Ops) | $0.50 | $0.60 | -$2.13 | $0.12 | $0.04 | |
Weighted Average Basic Share | $494.6M | $505.2M | $492.5M | $490.7M | $498.3M | |
Weighted Average Diluted Share | $495.6M | $506M | $493.6M | $491.8M | $499.2M | |
EBITDA | $524.2M | $551.4M | -$1.2B | $294.5M | $259.8M | |
EBIT | $336.9M | $375.1M | -$1.4B | $103.9M | $56.3M | |
Revenue (Reported) | $3.7B | $4.1B | $3.3B | $3.4B | $3.5B | |
Operating Income (Reported) | $279.8M | $351.4M | -$1.4B | $87.7M | $33.6M | |
Operating Income (Adjusted) | $336.9M | $375.1M | -$1.4B | $103.9M | $56.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $904.4M | $841M | $830.9M | $822.8M | |
Revenue Growth (YoY) | 49.85% | -21.98% | -7.02% | -1.19% | -0.97% | |
Cost of Revenues | $971.2M | $842.7M | $801.2M | $810.3M | $809.2M | |
Gross Profit | $188M | $61.7M | $39.7M | $20.6M | $13.7M | |
Gross Profit Margin | 16.22% | 6.82% | 4.73% | 2.48% | 1.66% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $34.9M | $33.7M | $32.2M | $44.5M | $30.5M | |
Operating Income | $153M | $28.1M | $7.5M | -$23.9M | -$16.8M | |
Net Interest Expenses | $6M | $6.7M | $1.1M | $1.1M | $5.3M | |
EBT. Incl. Unusual Items | $172.3M | $26.9M | $6.4M | -$22.8M | -$23.1M | |
Earnings of Discontinued Ops. | $28.9M | -- | $1.1M | -- | -- | |
Income Tax Expense | $37.4M | $7.9M | $2.1M | -$2.2M | -$5.3M | |
Net Income to Company | $172.3M | $26.9M | $6.4M | -$22.8M | -$23.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $163.9M | $18M | $4.3M | -$21.7M | -$17.9M | |
Basic EPS (Cont. Ops) | $0.33 | $0.04 | $0.01 | -$0.04 | -$0.04 | |
Diluted EPS (Cont. Ops) | $0.33 | $0.04 | $0.01 | -$0.04 | -$0.04 | |
Weighted Average Basic Share | $495M | $512.1M | $487.5M | $494.2M | $502.1M | |
Weighted Average Diluted Share | $495.8M | $513M | $488.7M | $495.4M | $503M | |
EBITDA | $220.5M | $78.5M | $55.8M | $33.7M | $35.8M | |
EBIT | $178.3M | $34.8M | $11.8M | -$16.3M | -$14.7M | |
Revenue (Reported) | $1.2B | $904.4M | $841M | $830.9M | $822.8M | |
Operating Income (Reported) | $153M | $28.1M | $7.5M | -$23.9M | -$16.8M | |
Operating Income (Adjusted) | $178.3M | $34.8M | $11.8M | -$16.3M | -$14.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $4.1B | $3.8B | $3.3B | $3.4B | $3.5B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $3.2B | $3.2B | $2.8B | $3B | $3.1B | |
Gross Profit | $922.3M | $687.2M | $481.8M | $456.5M | $422.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $480.3M | $460.2M | $1.8B | $399.6M | $383.7M | |
Operating Income | $442M | $227M | -$1.3B | $56.9M | $39.1M | |
Net Interest Expenses | $21.1M | $27.8M | $16.6M | $2.2M | $12.8M | |
EBT. Incl. Unusual Items | $509.3M | $213M | -$1.4B | $54.8M | $25.1M | |
Earnings of Discontinued Ops. | $41.8M | $5.6M | -$10.7M | -$13.5K | -$1.1M | |
Income Tax Expense | $119.5M | $58.1M | -$342.3M | $20.4M | $3.1M | |
Net Income to Company | $499.9M | $211.9M | $28M | $55.2M | $26.7M | |
Minority Interest in Earnings | -- | -$1.1M | -- | -- | -$1.1M | |
Net Income to Common Excl Extra Items | $433.8M | $159.3M | -$1B | $32.2M | $19.9M | |
Basic EPS (Cont. Ops) | $0.87 | $0.31 | -$2.08 | $0.07 | $0.04 | |
Diluted EPS (Cont. Ops) | $0.87 | $0.31 | -$2.11 | $0.07 | $0.04 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $700.4M | $410.5M | -$1.2B | $271.9M | $260.3M | |
EBIT | $524.4M | $232.8M | -$1.3B | $75.4M | $56.3M | |
Revenue (Reported) | $4.1B | $3.8B | $3.3B | $3.4B | $3.5B | |
Operating Income (Reported) | $442M | $227M | -$1.3B | $56.9M | $39.1M | |
Operating Income (Adjusted) | $524.4M | $232.8M | -$1.3B | $75.4M | $56.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $904.4M | $841M | $830.9M | $822.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $971.2M | $842.7M | $801.2M | $810.3M | $809.2M | |
Gross Profit | $188M | $61.7M | $39.7M | $20.6M | $13.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $34.9M | $33.7M | $32.2M | $44.5M | $30.5M | |
Operating Income | $153M | $28.1M | $7.5M | -$23.9M | -$16.8M | |
Net Interest Expenses | $6M | $6.7M | $1.1M | $1.1M | $5.3M | |
EBT. Incl. Unusual Items | $172.3M | $26.9M | $6.4M | -$22.8M | -$23.1M | |
Earnings of Discontinued Ops. | $28.9M | -- | $1.1M | -- | -- | |
Income Tax Expense | $37.4M | $7.9M | $2.1M | -$2.2M | -$5.3M | |
Net Income to Company | $172.3M | $26.9M | $6.4M | -$22.8M | -$23.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $163.9M | $18M | $4.3M | -$21.7M | -$17.9M | |
Basic EPS (Cont. Ops) | $0.33 | $0.04 | $0.01 | -$0.04 | -$0.04 | |
Diluted EPS (Cont. Ops) | $0.33 | $0.04 | $0.01 | -$0.04 | -$0.04 | |
Weighted Average Basic Share | $495M | $512.1M | $487.5M | $494.2M | $502.1M | |
Weighted Average Diluted Share | $495.8M | $513M | $488.7M | $495.4M | $503M | |
EBITDA | $220.5M | $78.5M | $55.8M | $33.7M | $35.8M | |
EBIT | $178.3M | $34.8M | $11.8M | -$16.3M | -$14.7M | |
Revenue (Reported) | $1.2B | $904.4M | $841M | $830.9M | $822.8M | |
Operating Income (Reported) | $153M | $28.1M | $7.5M | -$23.9M | -$16.8M | |
Operating Income (Adjusted) | $178.3M | $34.8M | $11.8M | -$16.3M | -$14.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $800.7M | $960.1M | $596.3M | $572.6M | $471.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $413.3M | $452.9M | $396.8M | $352.6M | $338.2M | |
Inventory | $3.7M | $5.7M | $7.5M | $9.9M | $10.4M | |
Prepaid Expenses | -- | $48.7M | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $1.5B | $1.5B | $1.1B | $1B | $952.1M | |
Property Plant And Equipment | $752.7M | $816.3M | $806.4M | $866.6M | $778.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $255.8M | $234.4M | $222M | $228.8M | $215.4M | |
Other Intangibles | $161.1M | $167.6M | $195.2M | $220M | $216.4M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2.7B | $2.8B | $2.4B | $2.4B | $2.2B | |
Accounts Payable | $173.4M | $190.2M | $195.2M | $232.1M | $184.2M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $77.5M | $73.6M | $80.4M | $88.4M | $81.2M | |
Other Current Liabilities | $32M | $6.8M | $7.5M | $13.3M | $4.2M | |
Total Current Liabilities | $1.1B | $1.1B | $1.1B | $1.4B | $971.9M | |
Long-Term Debt | $856.1M | $824.3M | $776.4M | $411.2M | $689.9M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.4B | $2.3B | $2.2B | $2.2B | $2B | |
Common Stock | $49.2M | $46.4M | $41.8M | $44.2M | $41.6M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $259.5M | $482.3M | $189.8M | $218.9M | $210.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $2.5M | $3.4M | $2.1M | $2.2M | $3.1M | |
Total Equity | $262M | $485.7M | $192M | $221.1M | $213.3M | |
Total Liabilities and Equity | $2.7B | $2.8B | $2.4B | $2.4B | $2.2B | |
Cash and Short Terms | $800.7M | $960.1M | $596.3M | $572.6M | $471.4M | |
Total Debt | $870.8M | $828.8M | $798.9M | $818M | $700.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $988.2M | $984.4M | $539.8M | $550.7M | $454.6M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $453.7M | $343.8M | $344.6M | $311M | $318.2M | |
Inventory | $3.5M | $6.7M | $8.7M | $13M | $10.8M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $1.6B | $1.5B | $1B | $989.2M | $961.1M | |
Property Plant And Equipment | $712.8M | $802.5M | $829.8M | $831.5M | $796.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $243.8M | $231M | $225.7M | $223.5M | $224M | |
Other Intangibles | $157.1M | $171.9M | $208.3M | $218.1M | $223M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2.8B | $2.8B | $2.4B | $2.3B | $2.3B | |
Accounts Payable | $157.1M | $148.4M | $200.6M | $182.5M | $179.7M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $71.5M | $71.4M | $81.8M | $85.3M | $85.5M | |
Other Current Liabilities | $172.3M | $146.2M | $125.4M | $126.3M | $120.1M | |
Total Current Liabilities | $1.1B | $1B | $1B | $1.4B | $990.3M | |
Long-Term Debt | $815.9M | $777.9M | $761.1M | $322.9M | $646.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.3B | $2.3B | $2.2B | $2.1B | $2B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $2.3M | $3.3M | $2.2M | $2.2M | $3.2M | |
Total Equity | $434.9M | $488.9M | $200.6M | $197.6M | $211.1M | |
Total Liabilities and Equity | $2.8B | $2.8B | $2.4B | $2.3B | $2.3B | |
Cash and Short Terms | $988.2M | $984.4M | $539.8M | $550.7M | $454.6M | |
Total Debt | $837M | $784.6M | $792.7M | $714.9M | $657M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $322.1M | $357.3M | $48.5M | $84.4M | $27.1M | |
Depreciation & Amoritzation | $187.3M | $176.3M | $164.5M | $190.5M | $203.5M | |
Stock-Based Compensation | $3.4M | $3.5M | $2.1M | $2.2M | $1.1M | |
Change in Accounts Receivable | -$66.2M | -$21.3M | $29.5M | $54.1M | -$5.4M | |
Change in Inventories | $1.1M | -$2.4M | -$2.1M | -$2.2M | -$1.1M | |
Cash From Operations | $206.7M | $532.4M | $253.1M | $240.3M | $181.8M | |
Capital Expenditures | $87.9M | $166.8M | $145.5M | $136.4M | $108.2M | |
Cash Acquisitions | $13.7M | $48.5M | -$2.1M | -- | $1.1M | |
Cash From Investing | $97.1M | -$108.9M | -$128.7M | -$110.4M | -$66M | |
Dividends Paid (Ex Special Dividend) | -- | -$133.7M | -$174M | -$31.4M | -$23.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.1M | -- | -- | $20.6M | $321.5M | |
Long-Term Debt Repaid | -$1.1M | -$5.9M | -$4.2M | -$55.2M | -$394M | |
Repurchase of Common Stock | -- | -- | -$173M | -- | -- | |
Other Financing Activities | -$1.1M | $1.2M | -$1.1M | -- | -- | |
Cash From Financing | -$91.4M | -$220.1M | -$430.3M | -$153.7M | -$187.2M | |
Beginning Cash (CF) | $548.2M | $770.3M | $894.3M | $601.9M | $560.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $195.3M | $233.1M | -$306.9M | -$41.1M | -$70.4M | |
Ending Cash (CF) | $743.5M | $1B | $586.4M | $560.8M | $490.3M | |
Levered Free Cash Flow | $118.8M | $365.6M | $107.6M | $103.9M | $73.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $172.3M | $26.9M | $6.4M | -$22.8M | -$23.1M | |
Depreciation & Amoritzation | $42.2M | $43.8M | $44M | $50M | $50.5M | |
Stock-Based Compensation | $1.2M | $1.1M | $1.1M | $1.1M | $1.1M | |
Change in Accounts Receivable | -$67.5M | $51.6M | $56.9M | $34.8M | $31.6M | |
Change in Inventories | -- | -$1.1M | -$1.1M | -$2.2M | -- | |
Cash From Operations | $185.6M | $103.2M | $23.6M | $25M | $8.4M | |
Capital Expenditures | $28.9M | $39.3M | $40.8M | $28.2M | $25.3M | |
Cash Acquisitions | $51.8M | -$1.1M | -- | $1.1M | -- | |
Cash From Investing | $27.7M | -$25.8M | -$36.5M | -$11.9M | -$21M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $4.8M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$1.1M | -- | |
Repurchase of Common Stock | -- | -$19.1M | -- | -- | -- | |
Other Financing Activities | -- | -$1.1M | -- | -- | -- | |
Cash From Financing | -$16.9M | -$39.3M | -$20.4M | -$21.7M | -$21M | |
Beginning Cash (CF) | $784.5M | $951.6M | $597.2M | $562.6M | $476.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $196.4M | $38.2M | -$65.5M | -$8.7M | -$33.7M | |
Ending Cash (CF) | $1B | $989.7M | $531.6M | $554M | $441.9M | |
Levered Free Cash Flow | $156.7M | $64M | -$17.2M | -$3.3M | -$16.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $499.9M | $211.9M | $28M | $55.2M | $26.7M | |
Depreciation & Amoritzation | $176.5M | $177.9M | $164.8M | $196.5M | $204M | |
Stock-Based Compensation | $3.5M | $3.5M | $2.1M | $2.2M | $1M | |
Change in Accounts Receivable | -$139.2M | $97.8M | $34.8M | $32M | -$8.6M | |
Change in Inventories | $1.1M | -$3.5M | -$2.1M | -$3.3M | $1.1M | |
Cash From Operations | $368M | $450.1M | $173.5M | $241.7M | $165.3M | |
Capital Expenditures | $108M | $177.2M | $147.1M | $123.8M | $105.2M | |
Cash Acquisitions | $57.8M | -$4.4M | -$987.1K | $1.1M | -$3.8K | |
Cash From Investing | $123.7M | -$162.4M | -$139.4M | -$85.9M | -$75.1M | |
Dividends Paid (Ex Special Dividend) | -- | -$133.7M | -$174M | -$31.4M | -$23.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $6M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$56.3M | -$392.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $61.1K | -- | -- | -- | |
Cash From Financing | -$88.4M | -$242.5M | -$411.4M | -$155M | -$186.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $385.1M | $74.8M | -$410.6M | $15.7M | -$95.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $260M | $272.9M | $26.4M | $117.9M | $60M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $172.3M | $26.9M | $6.4M | -$22.8M | -$23.1M | |
Depreciation & Amoritzation | $42.2M | $43.8M | $44M | $50M | $50.5M | |
Stock-Based Compensation | $1.2M | $1.1M | $1.1M | $1.1M | $1.1M | |
Change in Accounts Receivable | -$67.5M | $51.6M | $56.9M | $34.8M | $31.6M | |
Change in Inventories | -- | -$1.1M | -$1.1M | -$2.2M | -- | |
Cash From Operations | $185.6M | $103.2M | $23.6M | $25M | $8.4M | |
Capital Expenditures | $28.9M | $39.3M | $40.8M | $28.2M | $25.3M | |
Cash Acquisitions | $51.8M | -$1.1M | -- | $1.1M | -- | |
Cash From Investing | $27.7M | -$25.8M | -$36.5M | -$11.9M | -$21M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $4.8M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$1.1M | -- | |
Repurchase of Common Stock | -- | -$19.1M | -- | -- | -- | |
Other Financing Activities | -- | -$1.1M | -- | -- | -- | |
Cash From Financing | -$16.9M | -$39.3M | -$20.4M | -$21.7M | -$21M | |
Beginning Cash (CF) | $784.5M | $951.6M | $597.2M | $562.6M | $476.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $196.4M | $38.2M | -$65.5M | -$8.7M | -$33.7M | |
Ending Cash (CF) | $1B | $989.7M | $531.6M | $554M | $441.9M | |
Levered Free Cash Flow | $156.7M | $64M | -$17.2M | -$3.3M | -$16.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.